Plain-English translation of NCT04794075 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a structured education and nursing support program can help women with non-metastatic breast cancer manage the side effects of hormone therapy (anti-oestrogen or anti-aromatase medications) and improve their overall quality of life. Half of the participants will receive standard cancer care plus the new education and support program, which includes an initial assessment day and group workshops throughout the first year of treatment. The other half will receive standard cancer care alone, so researchers can compare how much the additional support helps.
Hormone therapy is an important treatment for breast cancer, but it can cause side effects that significantly affect how women feel and function day-to-day. This trial exists to see whether personalized education and ongoing nursing support can help patients better manage these side effects and maintain a better quality of life during their treatment.
You likely qualify if…
You likely don't qualify if…
If you join the experimental group, you will receive your regular cancer care plus participate in an initial educational assessment day at the hospital, followed by group workshops and nursing support throughout your first year of hormone therapy. If you are in the control group, you will receive standard cancer care only. All participants will use an online platform to report any side effects and complete questionnaires about how you're doing, so the researchers can compare how the two approaches work.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
France